Ethics & Informed Consent: Qualitative Interview & Focus Group Research (Portugal)
A detailed academic review of the ethical submission protocol, informed consent prerequisites, and reporting standards for conducting a Qualitative Interview & Focus Group Research within the regulatory framework of Portugal.
1. Ethical Principles & Legislative Framework
In research involving human participants, securing ethical clearance is a critical first step. For a Qualitative Interview & Focus Group Research being conducted in Portugal, study designs must align with the primary regulatory legislation: Clinical Research Act (Law 21/2014). This statutory framework ensures participant welfare, confidentiality, and voluntary involvement are protected.
National Ethics Board Clearance Pathway
In Portugal, clinical studies require review by CEIC and/or institutional CES. Consent documents must specify data ownership and meet INFARMED standards.
Administrative review and formal approval are managed by a local or regional Comissão de Ética para a Investigação Clínica (CEIC). Researchers must secure full approval or a formal exemption certificate from this board before recruiting any participants or commencing data collection.
2. Study Design Elements & Reporting Integrity
For a Qualitative Interview & Focus Group Research, the review board places significant focus on methodological transparency. The application must outline the research rationale, recruitment protocols, inclusion and exclusion criteria, and data protection measures.
Study Classification: Minimal Risk
Dialogue is the core data of qualitative designs. Consent sheets must detail how identifiers will be scrubbed from transcripts, and remind focus group participants of mutual privacy limits.
To guarantee academic integrity and reproducibility, the study report and subsequent publications should follow the internationally recognised reporting standard: COREQ checklist.
Special Directive: Observational Study Protocols
As an observational or non-interventional design, the ethics board primarily focuses on data privacy, secure pseudonymisation, and informed consent. If you are conducting retrospective database research, you may apply for a waiver of consent, provided participant risk is minimised.
3. Informed Consent & Information Sheet Guidelines
A robust participant information sheet and informed consent form are critical parts of the ethical application. Ensure your documentation incorporates the following components:
Design-Specific Consent Focus Areas
Explicit consent for audio/video recording, publication of anonymised verbatim quotes, and focus group privacy rules.
- Plain Language Explanations: Avoid complex medical or technical terminology. Ensure readability matches the general population.
- Voluntary Participation: Explicitly state that participation is entirely voluntary and that individuals can withdraw at any time without negative consequences.
- Confidentiality & Data Controls: Explain how participant data will be anonymised or pseudonymised, who will have access to it, and how long it will be securely retained under EU GDPR & Portuguese Data Protection Act (Law 58/2019).
- Risk/Benefit Disclosure: Clearly list any potential risks, discomforts, or direct benefits associated with participation in the study.
- Ethics Board Contact Information: Provide the contact details of the reviewing Comissão de Ética para a Investigação Clínica (CEIC) so participants can reach out if they have questions or concerns.
Research Ethics, Clinical Trials & Institutional Governance
Applying the Declaration of Helsinki ethical principles to this qualitative Qualitative Interview & Focus Group Research means respecting participant self-determination. To prevent historical lapses of trust reminiscent of the Tuskegee syphilis study ethics disaster, researchers must secure absolute confidentiality. The consenting workflow must actively support the ethical principles of informed consent, ensuring full transparency. Staff must complete institutional human subjects research training and maintain active protocols for the continuing review irb cycles. Submitting a robust data privacy plan is the final step to secure complete research ethics approval from the Comissão de Ética para a Investigação Clínica (CEIC). Ethical oversight committees in Portugal audit the study's consent registry periodically to verify compliance with national legal statutes.
4. Regulatory Checklist Table
To streamline your ethical review submission, use the structured alignment checklist below:
| Requirement | Comissão de Ética para a Investigação Clínica (CEIC) Standard | COREQ checklist Standard |
|---|---|---|
| Consent Form | Signed and dated prior to study activity. Focus: Explicit consent for audio/video recording. | Fully documented recruitment and consent paths. |
| Risk Management | Comprehensive risk mitigation plan. Prompt transcription with immediate pseudonymisation, encrypted audio storage, and secure deletion of primary recordings. | Adverse events reporting strategy. |
| Data Retention | Compliance with local data protection rules (EU GDPR & Portuguese Data Protection Act (Law 58/2019)). | Provision of open-data options where possible. |
5. Academic & Research Infrastructure Matrix (Portugal)
The following authenticated registry lists top scientific organizations, clinical laboratories, and research hospitals in Portugal mapped via the Research Organization Registry (ROR) standards-compliance framework.
| Organization Name | Sector Type | Registry Identification |
|---|---|---|
| Altice Portugal (Portugal) | company | ROR IDWikidata/Wiki |
| Teva Portugal | company | ROR ID |
| Livraria Portugal (Portugal) | company | ROR ID |
| Alfasigma Portugal (Portugal) | company | ROR ID |
| Affidea Portugal | company | ROR ID |
| Logiters Portugal | company | ROR ID |
| WSA Portugal (Portugal) | company | ROR ID |
| Vygon Portugal | company | ROR ID |
| Upstream Portugal | company | ROR ID |
| MPO Portugal (Portugal) | company | ROR ID |
| SHL Portugal | company | ROR ID |
| SGS Portugal (Portugal) | company | ROR ID |
| Deloitte Portugal (Portugal) | company | ROR ID |
| Águas de Portugal (Portugal) | company | ROR IDWikidata/Wiki |
| Infraestruturas de Portugal (Portugal) | company | ROR ID |
6. Frequently Asked Questions
How long does the review process normally take?
Review timelines depend on the volume of applications and whether your proposal qualifies for expedited review. On average, a standard review by an ethics board in Portugal takes between 4 to 8 weeks.
Can we use digital signatures for informed consent?
Yes, digital consent forms are increasingly accepted, provided the platform used is secure, authenticates the identity of the signer, and complies with local regulations such as the eIDAS or ESIGN Act, depending on country-specific rules.
Regulatory Context
Verified Funding Bodies
Funder registries and DOI configurations verified for compliance in Portugal via Crossref.
- Comité Olímpico de PortugalID: 501100023847 | Location: Portugal
- Carnegie Mellon PortugalID: 100019678 | Location: Portugal
- Bayer PortugalID: 501100019189 | Location: Portugal
- Fulbright PortugalID: 501100014070 | Location: Portugal
- MIT PortugalID: 501100019186 | Location: Portugal
- Banco de PortugalID: 501100019247 | Location: Portugal
- Fundação Portugal TelecomID: 501100008683 | Location: Portugal
- Novartis PortugalID: 100020604 | Location: Portugal
- Fundação GrünenthalID: 501100010289 | Location: Portugal
- OSRAMID: 100031434 | Location: Portugal
Pre-Submission Warning
Do not recruit participants or initiate study procedures before receiving official written approval from your reviewing board. Ethical approvals cannot be granted retrospectively under Clinical Research Act (Law 21/2014).







